Remedi HS Drug Profiling System

FDA 510(k) K941596 · Bio-Rad

Substantially Equivalent

510(k) numberK941596

Submission

Device name
Remedi HS Drug Profiling System
Applicant
Bio-Rad
Hercules, CA, US
Received
April 1, 1994
Decision date
March 27, 1995
Decision
Substantially Equivalent (SESE)
Type
Traditional 510(k)
Summary
510(k) summary available from FDA

Official FDA 510(k) record

Device classification

Product code
DNI – Liquid Chromatography, Amphetamine
Device class
Class II (moderate risk)
Regulation
21 CFR 862.3100
Specialty
Clinical Toxicology

More from Bio-Rad

510(k)DeviceDecision
K171061MRSASelect IIJSO · Traditional 12/28/2017SE
K122187Vreselect Culture MediumJSO · Traditional 11/06/2012SE
K103684Vreselect Culture MediumJSO · Traditional 10/21/2011SE
K093678Platelia Aspergillus Eia Model 62793NOM · Traditional 01/13/2011SE
K100589Mrsa Select - Skin and Soft Tissue Wound SpecimensJSO · Traditional 10/29/2010SE
K081362Platelia Lyme IgmLSR · Traditional 06/26/2008SE
K081212Mrsaselect - Extended IncubationJSO · Traditional 06/13/2008SE
K080012Platelia Lyme Igg AssayLSR · Traditional 05/08/2008SE
K070361MrsaselectJSO · Traditional 09/13/2007SE
K060641Platelia Aspergillus Eia, Model 62793NOM · Traditional 06/02/2006SE

Questions and answers

When was Remedi HS Drug Profiling System cleared by the FDA?

Remedi HS Drug Profiling System (K941596) received a 510(k) decision of Substantially Equivalent on March 27, 1995, 360 days after the submission was received.

What is the product code of K941596?

The FDA product code is DNI – Liquid Chromatography, Amphetamine, a Class II (moderate risk) device regulated under 21 CFR 862.3100.